169 results found for 'dental-implant-price-168002.asia'.
Solutions identified to enable affordable medicines for hepatitis C, Unitaid new report highlights
News | 12 February 2015
...Médecins Sans Frontières (MSF) to demonstrate the feasibility of treating hepatitis C with these new medicines in resource limited settings, including through reducing prices. The UNITAID report highlights interlinked ways...
FIND and Unitaid invest to support technology transfer and boost local production of COVID-19 rapid tests in low- and middle-income countries
News | 15 July 2021
...2 million tests per month, with a ceiling price of US$2.00 (ex-works). To serve the African continent, DIATROPIX of the Institut Pasteur de Dakar in Senegal is being supported to...
Medicines We Can Trust Campaign Rallies Mekong Governments and Leaders to Improve Access to Quality Medicines
News | 07 November 2018
...in low- and middle-income countries, including many countries in Asia Pacific. In Southeast Asia alone, an estimated 30% of antimalarial drugs are of poor-quality contributing to an alarming rise in...
Unitaid commits US$ 56 million to boost access to medical oxygen globally, calls on other donors to close US$ 1 billion gap
News | 17 March 2022
...of market competition in countries resulting in high prices and fragmented access. These investments directly support the work of the Access to COVID-19 Tools Accelerator (ACT-A) Oxygen Emergency Taskforce (Oxygen...
World Hepatitis Day: Why Unitaid is investing in hepatitis C
News | 28 July 2014
...(HCV). These interventions will result in significant price reductions for drugs and increase access to desperately needed diagnostics (see below) for millions of people. What is Hepatitis C and why...
Drug price cut will expand access to a key treatment for HIV coinfections
News | 12 September 2018
GENEVA – Unitaid welcomes the announcement by Gilead Sciences, Inc. that it will cut the price of the WHO-recommended drug AmBisome® to treat cryptococcal meningitis, an opportunistic infection that is...
Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries
News | 26 July 2021
...US$210 per patient per year, or US$17.50/pack (plus shipping and insurance). This price is cheaper than the well-established but suboptimal alternative option, lopinavir/ritonavir (LPV/r). Kenly Sikwese, HIV advocate and head...
Health leaders see partnership driving innovation
News | 18 May 2015
...of Health for South Africa, Aaron Motsoaledi, said UNITAID and the Medicines Patent Pool had played a big part in bringing down the prices of antiretroviral drugs and putting large...
Portable thermal ablation devices allow more women to access lifesaving cervical cancer prevention in countries where the majority of deaths occur
News | 16 May 2022
...who can safely offer treatment of precancerous lesions, which is critical in preventing the progression to cancer. Furthermore, with recently announced ‘access’ prices for thermal ablation devices, this treatment method...
South Africa to introduce state-of-the-art HIV treatment
News | 27 November 2019
...heavily over the last three years in better antiretrovirals. Efforts include four clinical trials, funding to the Medicines Patent Pool for affordable generics, market-shaping interventions to lower prices, and technical...